TARGETING CHROMATIN REMODELING COMPLEXES TO INHIBIT ONCOGENIC ANDROGEN RECEPTOR ACTIVITY IN PROSTATE CANCER.

$900,640FY2021Department of the ArmyDOD

Regents Of The University Of Michigan

Investigators